Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer - PubMed (original) (raw)
Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer
Wei Hu et al. Oncol Res. 2005.
Abstract
The STK15 (also known as Aurora-A/BTAK) gene localized on chromosome 20q13 and encoding a centrosome-associated serine/threonine kinase is amplified and overexpressed in multiple human tumor cell types. Overexpression of this gene is involved in tumorigenic transformation, induction of centrosome duplication-distribution abnormalities, and aneuploidy in mammalian cells. To examine the potential role of STK15 in ovarian tumorigenesis, its mRNA and protein expression status were examined in cells grown in culture from 15 ovarian cancer specimens using semiquantitative RT-PCR and Western blot analysis. Normal ovarian surface tissues and the near diploid nontumorigenic breast epithelial cell line MCF10 were used as controls. The status of STK15 correlated with transformation-associated cellular phenotypes including tumorigenicity in nude mice, p53 expression level, and chromosomal ploidy. For chromosome ploidy analyses, FISH was carried out with direct fluorescence-labeled a-satellite probes for chromosome 3 and 17. STK15 mRNA was found overexpressed in 10 of the 15 ovarian cancer cell cultures. Five of these cell cultures revealed a truncated form of the STK15 protein with a molecular mass of 36 kDa. When tested for tumorigenicity in nude mice, 9 of the 10 cell cultures that overexpressed STK15 mRNA formed tumors in nude mice, while only one of the five cell cultures with no overexpression did. Cells overexpressing STK15 mRNA showed significant correlation with chromosome 3 polysomy. Six of the 13 (46%) cell cultures analyzed for p53 expression revealed overexpression of p53 and five of these six (83%) also overexpressed STK15. Four of the remaining seven cultures (57%) with overexpression of STK15 revealed minimal or no expression of p53. These results demonstrate that overexpression of STK15 significantly correlates with nude mice tumorigenicity and chromosomal aneuploidy in human ovarian cancer cells grown in vitro. Additionally, cells overexpressing STK15 also revealed frequent coordinate loss of wild-type p53 function manifested either as highly expressed intense staining reflective of a mutant form of p53 or almost complete absence of p53 staining. Overexpression of STK15 with coordinate loss of wild-type p53 function thus appears to play an important role in ovarian tumorigenesis and offers a novel molecular target in designing effective therapy of human ovarian cancer.
Similar articles
- Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L, Amato A, Schillaci T, Di Leonardo A. Lentini L, et al. BMC Cancer. 2007 Nov 13;7:212. doi: 10.1186/1471-2407-7-212. BMC Cancer. 2007. PMID: 17999753 Free PMC article. - Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S. Zhou H, et al. Nat Genet. 1998 Oct;20(2):189-93. doi: 10.1038/2496. Nat Genet. 1998. PMID: 9771714 - Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers.
Miyoshi Y, Iwao K, Egawa C, Noguchi S. Miyoshi Y, et al. Int J Cancer. 2001 May 1;92(3):370-3. doi: 10.1002/ijc.1200. Int J Cancer. 2001. PMID: 11291073 - The Aurora kinases: role in cell transformation and tumorigenesis.
Katayama H, Brinkley WR, Sen S. Katayama H, et al. Cancer Metastasis Rev. 2003 Dec;22(4):451-64. doi: 10.1023/a:1023789416385. Cancer Metastasis Rev. 2003. PMID: 12884918 Review. - Functional Significance of Aurora Kinases-p53 Protein Family Interactions in Cancer.
Sasai K, Treekitkarnmongkol W, Kai K, Katayama H, Sen S. Sasai K, et al. Front Oncol. 2016 Nov 25;6:247. doi: 10.3389/fonc.2016.00247. eCollection 2016. Front Oncol. 2016. PMID: 27933271 Free PMC article. Review.
Cited by
- Aurora A kinase is required for activation of the Fanconi anemia/BRCA pathway upon DNA damage.
Chun MJ, Hwang SK, Kim HG, Goh SH, Kim S, Lee CH. Chun MJ, et al. FEBS Open Bio. 2016 Jun 8;6(7):782-90. doi: 10.1002/2211-5463.12087. eCollection 2016 Jul. FEBS Open Bio. 2016. PMID: 27398318 Free PMC article. - Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells.
Scharer CD, Laycock N, Osunkoya AO, Logani S, McDonald JF, Benigno BB, Moreno CS. Scharer CD, et al. J Transl Med. 2008 Dec 11;6:79. doi: 10.1186/1479-5876-6-79. J Transl Med. 2008. PMID: 19077237 Free PMC article. - AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma.
Yang F, Guo X, Yang G, Rosen DG, Liu J. Yang F, et al. Mod Pathol. 2011 Jun;24(6):836-45. doi: 10.1038/modpathol.2011.44. Epub 2011 Mar 25. Mod Pathol. 2011. PMID: 21441901 Free PMC article. - Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.
Lin YG, Immaneni A, Merritt WM, Mangala LS, Kim SW, Shahzad MM, Tsang YT, Armaiz-Pena GN, Lu C, Kamat AA, Han LY, Spannuth WA, Nick AM, Landen CN Jr, Wong KK, Gray MJ, Coleman RL, Bodurka DC, Brinkley WR, Sood AK. Lin YG, et al. Clin Cancer Res. 2008 Sep 1;14(17):5437-46. doi: 10.1158/1078-0432.CCR-07-4922. Clin Cancer Res. 2008. PMID: 18765535 Free PMC article. - Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.
Do TV, Xiao F, Bickel LE, Klein-Szanto AJ, Pathak HB, Hua X, Howe C, O'Brien SW, Maglaty M, Ecsedy JA, Litwin S, Golemis EA, Schilder RJ, Godwin AK, Connolly DC. Do TV, et al. Oncogene. 2014 Jan 30;33(5):539-49. doi: 10.1038/onc.2012.632. Epub 2013 Jan 21. Oncogene. 2014. PMID: 23334327 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous